SAH (diagnosed)
Vasospasm (initial)
Intestinal obstruction (medical)
Intestinal obstruction (surgical)
Abdominal Compartment Syndrome (conservative)
Abdominal Compartment Syndrome (surgical)
BB CCB overdose (suspected)
Initial Assessment and Stabilization:
- Check vital signs.
- ABCDEF approach; secure the airway.
- Administer oxygen, consider non-invasive ventilation (BiPAP).
- Insert two large peripheral IV cannulas.
- Insert Foley’s catheter.
- Start cardiac monitoring, obtain ECG.
Investigations:
- CBC, electrolytes, renal function tests (RFT), random blood sugar (RBS), TSH, liver function tests (LFT), cardiac enzymes, BNP, coagulation profile.
- Arterial blood gas (ABG).
- Chest X-ray (CXR).
- Toxicology screen.
Medication and Hemodynamic Support:
- Administer atropine 0.3-0.5 mg IV every 5 minutes up to 3 mg for bradycardia.
- Start dopamine (2-10 μg/kg/min) or epinephrine (2-10 μg/min) for hypotension.
- Consult cardiology for transcutaneous pacing if needed.
- Initiate IV diuresis after stabilizing hemodynamics.
Toxicology Management:
- Administer activated charcoal within the first 4 hours of ingestion.
- Calcium gluconate 3-6 gm IV, or calcium chloride 1-3 gm IV.
- Glucagon 50-150 μg/kg stat, followed by an infusion of 50-100 μg/kg/hr.
Continuous Monitoring and Reassessment:
- Monitor vital signs, ECG, and response to treatments continuously.
- Adjust management based on clinical status and investigation results.
- Ensure multidisciplinary approach involving cardiology, toxicology, and critical care.
Further management:
- ICU admission for monitoring of the VS
- Frequent monitoring of serum K and RBS
- Psychiatry consultation
Thyroid storm
Pulmonary hypertension
Vasopressors:
Inotropes:
Variceal bleeding
Acute pancreatitis and concurrent acute cholangitis
endoscopic retrograde cholangiopancreatography (ERCP) within 24 h of admission.
Feeding in acute pancreatitis
In mild AP, oral feedings can be started immediately if there is no nausea and vomiting. In severe AP, enteral nutrition is recommended to prevent infectious complications, whereas parenteral nutrition should be avoided.
Acute pancreatitis (surgery)
Trauma
Lower GI bleeding
Headache
Asthma
Initial Assessment:
Diagnostic Investigations:
Immediate Management:
Cardiogenic shock
Seizure in HIV-Positive Patient
Stabilization:
- Airway management (assess for patency, protection)
- Breathing and circulation support
- Seizure control (benzodiazepines like lorazepam)
Diagnostic Evaluation:
- Blood tests: CBC, electrolytes, renal function, liver enzymes, glucose
- Lumbar puncture (if no contraindication) for CSF analysis
- Imaging: MRI brain (preferred) or CT scan
- EEG if recurrent seizures
Management of Seizure:
Consultations:
- Consult Infectious Disease for antiretroviral therapy
- Neurology Consultation
Follow-up and Monitoring:
- ICU
Status Epilepticus
Initial Seizure Control:
- Benzodiazepines first-line: Lorazepam IV, followed by Diazepam or Midazolam if needed.
Second-Line Antiepileptics:
- Phenytoin/Fosphenytoin: Adjust dose for therapeutic levels.
- Levetiracetam (Keppra): Advantageous due to minimal drug interactions, renal dose adjustment.
- Valproate: Monitor for hepatic metabolism and drug interactions.
Management of Refractory Status Epilepticus:
- Continuous EEG monitoring.
- Phenobarbital: If seizures persist after initial treatments.
- Propofol or Midazolam infusion: Considered for ongoing seizures, requires ICU.
Airway Management (if needed):
- Rapid Sequence Intubation (RSI) for airway protection, especially if patient is in status epilepticus and unable to protect airway.
Use of Anesthetic Agents:
- General anesthetics like Thiopental or Pentobarbital for intractable seizures.
TB menegitis
Antituberculous Therapy:
- Rifampicin
- Isoniazid (with Pyridoxine to prevent neuropathy)
- Pyrazinamide
- Ethambutol or Streptomycin (especially if drug resistance is suspected)
Duration: Intensive phase for 2 months, followed by continuation phase for at least 4-7 months.
Corticosteroids:
- Dexamethasone or Prednisolone
- Reduces inflammation and improves outcomes.
Monitoring and Adjustments:
- Monitor liver function tests (antituberculous drugs can be hepatotoxic).
- Adjust dosages based on renal and liver function.
Supportive Care:
- Manage raised intracranial pressure.
- Symptomatic treatment for headache, fever.
- Nutritional support and hydration.
HIV Management:
- Antiretroviral therapy (ART) initiation or adjustment.
- Monitor for drug-drug interactions between ART and TB medications.
Follow-up:
- Regular CSF analysis to monitor response.
- Neurological assessment to evaluate for any complications.
Infection Control:
- Isolation until non-infectious (if pulmonary TB is also present).
- Contact tracing and screening.
COVID ARDS (initial)
ARDS (diagnosed)
Post CABG handover